LIVN Q1 2017 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$285M-0.7% YoY

Gross Profit

$184M64.7% margin

Operating Income

-$19M-6.5% margin

Net Income

$11M4.0% margin

EPS (Diluted)

$0.23

QoQ Revenue Growth

-8.2%

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$26M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$636M

Stockholders' Equity

$1.7B

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$285M	$287M	-0.7%
Gross Profit	$184M	$163M	+12.9%
Operating Income	-$19M	-$36M	+48.4%
Net Income	$11M	-$40M	+127.9%

Revenue Segments

Cardiac Surgery

$139M49%

Neuromodulation

$87M31%

Cardiac Rhythm Management

$58M20%

Geographic Segments

UNITED STATES

$114M36%

Europe

$96M30%

Non-U.S. and Europe

$74M23%

FRANCE

$33M10%